Acadia Pharma
ACAD----
Acadia Pharma (ACAD)
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in Nor...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Acadia Pharma Analyst Rating
View MoreForecast & Rating
Jul 21, 2026Price forecast
$32.8032.47%
Forecast & RatingBuy
21analysts
- Strong buy57.14%
- Buy19.05%
- Hold19.05%
- Sell4.76%
- Strong sell0.00%
News
- benzinga_article · Jul 21 at 06:51 AM
Robinhood To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday
- PUBT · Jul 20 at 08:07 AM
ACADIA issues press release on FDA Fast Track designation for remlifanserin in Alzheimer’s disease psychosis
- Simplywall · Jul 18 at 12:05 PM
ACADIA Pharmaceuticals (ACAD) Stock Trades At A Discount To Earnings But Faces Concentrated Risk
- PUBT · Jul 15 at 03:05 PM
Acadia Pharmaceuticals to report Q2 results and host conference call
- StockTitan · Jul 6 at 12:04 AM
Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer | ACAD Stock News
- PUBT · Jun 29 at 05:00 PM
Acadia Pharmaceuticals principal accounting officer James Kihara sells 11,421 shares for $297,940.30
